{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T08:41:36Z","timestamp":1648888896649},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cjca.2019.10.014","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T05:55:12Z","timestamp":1571378112000},"page":"22-23","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Failure of Statins to Improve Outcomes in Dialysis Patients: Does Peritonitis Modify the Impact of Lipids on Cardiovascular Events?"],"prefix":"10.1016","volume":"36","author":[{"given":"Dirk G.","family":"Struijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.10.014_bib1","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1046\/j.1523-1755.2002.00262.x","article-title":"A\u00a0placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD","volume":"61","author":"Harris","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.10.014_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/ajkd.2002.30547","article-title":"Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis","volume":"39","author":"Saltissi","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjca.2019.10.014_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.10.014_bib4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.kint.2015.12.033","article-title":"Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis","volume":"89","author":"Krane","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.10.014_bib5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.10.014_bib6","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2019.10.014_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000357676","article-title":"Meta-analysis of lipid-lowering therapy in maintenance dialysis patients","volume":"124","author":"Green","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.cjca.2019.10.014_bib8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3109\/0886022X.2015.1061871","article-title":"Meta-analysis of statin therapy in maintenance dialysis patients","volume":"37","author":"Sun","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.cjca.2019.10.014_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/nep.12435","article-title":"Statins for end-stage kidney disease treated with dialysis","volume":"20","author":"Webster","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.cjca.2019.10.014_bib10","first-page":"259","article-title":"KDIGO clinical practice guideline for lipid management in chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.10.014_bib11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.10.014_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/0886022X.2016.1260032","article-title":"Opinions of nephrologists on the efficacy and tolerance of statins in hemodialysis patients","volume":"39","author":"Budzisz","year":"2017","journal-title":"Ren Fail"},{"key":"10.1016\/j.cjca.2019.10.014_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","author":"Herrington","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cjca.2019.10.014_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.10.014_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/ATVBAHA.113.301301","article-title":"Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation","volume":"34","author":"Chen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2019.10.014_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/eci.12718","article-title":"Does statins [sic] promote vascular calcification in chronic kidney disease?","volume":"47","author":"Chen","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cjca.2019.10.014_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cjca.2019.08.028","article-title":"Peritonitis affects the relationship between low-density lipoprotein cholesterol and cardiovascular events in peritoneal dialysis patients","volume":"36","author":"Ye","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.10.014_bib18","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3389\/fimmu.2017.01836","article-title":"Macrophage-bacteria interactions\u2014a lipid-centric relationship","volume":"8","author":"Teng","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.cjca.2019.10.014_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000093513","article-title":"MIA syndrome in peritoneal dialysis: prevention and treatment","volume":"150","author":"Shahab","year":"2006","journal-title":"Contrib Nephrol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19313492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19313492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T15:47:30Z","timestamp":1577116050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19313492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0828282X19313492"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.10.014","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Failure of Statins to Improve Outcomes in Dialysis Patients: Does Peritonitis Modify the Impact of Lipids on Cardiovascular Events?","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.08.028","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}